Search results for "Embryo implantation"

showing 10 items of 92 documents

The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.

2014

STUDY QUESTION: Does the combined oral contraceptive pill (COCP) change endometrial gene expression when used for cycle programming? SUMMARY ANSWER: COCP used for scheduling purposes does not have a significant impact on endometrial gene expression related to endometrial receptivity. WHAT IS KNOWN ALREADY: Controversy exists around COCP pretreatment for IVF cycle programming as some authors claim that it might be detrimental to the live birth rate. Microarray technology applied to the study of tissue gene expression has previously revealed the behavior of genes related to endometrial receptivity under different conditions. STUDY DESIGN SIZE AND DURATION: Proof-of-concept study of 10 young h…

Adultmedicine.medical_specialtyAdolescentmedicine.medical_treatmentPopulationUterusGene ExpressionEndometriumEndometriumYoung AdultOvulation InductionmedicineHumansEmbryo ImplantationeducationMenstrual CycleGynecologyeducation.field_of_studyPregnancymedicine.diagnostic_testGenitourinary systembusiness.industryRehabilitationObstetrics and Gynecologymedicine.diseaseContraceptives Oral Combinedmedicine.anatomical_structureReproductive MedicineFemaleCombined oral contraceptive pillLive birthbusinessEndometrial biopsyHuman reproduction (Oxford, England)
researchProduct

Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics anal…

2011

Elevated serum progesterone levels at the end of the follicular phase in controlled ovarian stimulation (COS) leads to a poorer ongoing pregnancy rate in IVF cycles due to reduced endometrial receptivity. The objective of this study was to use microarray technology to compare endometrial gene expression profiles at the window of implantation according to the levels of circulating progesterone.For this prospective cohort study, microarray data were obtained from endometrial biopsies from 12 young healthy oocyte donors undergoing COS with pituitary suppression by either gonadotrophin-releasing hormone (GnRH) agonists or antagonists, and recombinant FSH. On the day of recombinant chorionic gon…

Adultmedicine.medical_specialtyBiologyEndometriumAndrologyEndometriumImmune systemOvulation InductionPregnancyInternal medicineProgesterone receptorGene expressionFollicular phasemedicineHumansEmbryo ImplantationProspective StudiesCell adhesionGeneProgesteroneOligonucleotide Array Sequence Analysisbusiness.industryGene Expression ProfilingRehabilitationObstetrics and GynecologyGeneral MedicineGenomicsGene expression profilingPregnancy rateEndocrinologymedicine.anatomical_structureFollicular PhaseGene Expression RegulationReproductive MedicineFemaleEndometrial receptivitybusinessFunctional genomicsHuman Reproduction
researchProduct

Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients

2003

Implantation failure (IF) is defined as three or more failed IVF attempts, and preimplantation genetic diagnosis (PGD) is being used in these patients to improve IVF outcome. PGD was performed in 49 implantation failure patients with a mean number of 4.2 +/- 1.6 previous IVF failures, and in nine fertile controls. Fluorescence in-situ hybridization (FISH) on blastomeres from biopsied day 3 embryos was performed for chromosomes 13, 16, 18, 21, 22, X and Y. There was a significantly higher rate of chromosomal abnormalities (67.4%) compared with controls (36.3%). In 57 cycles, a pregnancy rate of 34.0% and an implantation rate of 19.8% was observed in implantation failure patients compared wit…

Adultmedicine.medical_specialtyBiopsyPregnancy High-RiskAneuploidyFertilization in VitroPreimplantation genetic diagnosisPregnancyBiopsyHumansMedicineEmbryo ImplantationBlastocystIn Situ Hybridization FluorescencePreimplantation Diagnosisreproductive and urinary physiologyChromosome AberrationsGynecologyPregnancymedicine.diagnostic_testbusiness.industryObstetricsBlastocyst TransferObstetrics and GynecologyAneuploidyEmbryo Transfermedicine.diseaseCoculture TechniquesEmbryo transferPregnancy rateTreatment Outcomemedicine.anatomical_structureReproductive Medicineembryonic structuresFemalebusinessMaternal AgeDevelopmental BiologyReproductive BioMedicine Online
researchProduct

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women und…

2007

Background Ovarian hyperstimulation syndrome (OHSS) is a result of ovarian overexpression of vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR2). VEGF/VEGFR2 binding disrupts cellular junctions and increases vascular permeability (VP), a characteristic of OHSS, but enhances angiogenesis, which is a fundamental step in implantation. In animals, the dopamine agonist Cabergoline (Cb2) prevents VP without affecting angiogenesis. In humans, Cb2 averts OHSS, but a possible detrimental effect on angiogenesis and implantation has not been explored. A pilot study was designed to analyze whether or not Cb2 administration, as a procedure for preventing OHSS, affects the outcome of as…

Adultmedicine.medical_specialtyCabergolinePregnancy RateReproductive Techniques AssistedOvarian hyperstimulation syndromePilot ProjectsBiologyDopamine agonistAndrologyOvarian Hyperstimulation Syndromechemistry.chemical_compoundPregnancyCabergolineInternal medicinemedicineHumansEmbryo ImplantationErgolinesOvarian follicleRetrospective StudiesPregnancyRehabilitationObstetrics and Gynecologymedicine.diseaseVascular endothelial growth factorPregnancy ratemedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryDopamine AgonistsGestationFemalemedicine.drugHuman Reproduction
researchProduct

Effect of an intrauterine device on the gene expression profile of the endometrium.

2006

The human endometrium acquires the ability to allow embryo attachment just for a specific period of time during each menstrual cycle. Understanding of the opposite functional status, referred to as refractoriness, can potentially be used to improve receptivity in infertile patients or as an interceptive approach to prevent gestation.The objective of the study was to analyze the endometrial gene expression profile induced by an inert intrauterine device (IUD) at the time of implantation.We used a microarray containing more than 16,000 cDNAs to investigate the gene expression profile of receptive vs. refractory endometrium in the same women induced by the presence of an IUD. We compared the g…

Adultmedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectClinical BiochemistryUterusContext (language use)BiologyEndometriumIntrauterine deviceBiochemistryEndometriumEndocrinologyInternal medicinemedicineHumansEmbryo ImplantationMenstrual cyclemedia_commonOligonucleotide Array Sequence AnalysisRegulation of gene expressionGlycodelinGene Expression ProfilingBiochemistry (medical)medicine.anatomical_structureEndocrinologyGene Expression RegulationIn uteroFemaleIntrauterine DevicesThe Journal of clinical endocrinology and metabolism
researchProduct

Impact of chromosomal abnormalities on preimplantation embryo development.

2007

Objectives To evaluate the influence of numerical chromosomal abnormalities on preimplantation embryo development. Methods This study includes 6936 embryos from 1245 women undergoing preimplantation genetic diagnosis (PGD). Indications for aneuploidy screening were: recurrent miscarriages, implantation failure, severe male factor, advanced maternal age, and mixed causes. Embryo biopsy was performed on day 3, and embryos were co-cultured until day 5, when embryo transfer was performed. Results In the aneuploidy screening regimen, normal euploid embryos showed significantly higher blastocyst rates (68.2%) compared to chromosomally abnormal (42.8%, p < 0.0001) and mosaic (53.7%, p < 0.0001) em…

Adultmedicine.medical_specialtyMonosomyanimal structuresAneuploidyEmbryonic DevelopmentTrisomyFertilization in VitroBiologyPreimplantation genetic diagnosisPregnancyCulture TechniquesmedicineHumansBlastocystAdvanced maternal ageEmbryo ImplantationGenetic TestingGenetics (clinical)In Situ Hybridization FluorescencePreimplantation DiagnosisGynecologyChromosomes Human XMosaicismObstetrics and GynecologyEmbryomedicine.diseaseAneuploidyEmbryo transfermedicine.anatomical_structureBlastocystembryonic structuresFemaleTrisomyMaternal AgePrenatal diagnosis
researchProduct

Live birth after embryo transfer in an unresponsive thin endometrium.

2014

A healthy term livebirth in a 35-year-old woman with ovarian failure, hypoplastic uterus and atrophic endometrium after cancer treatment with chemotherapy and radiotherapy was achieved by ovum donation. The detection of a receptive endometrium using a new diagnostic tool of endometrial receptivity encouraged the medical team to carry on with this poor prognosis case. To the best of our knowledge, here we report the thinnest endometrium to date in which a healthy, full term live birth has been described in assisted conception.

Adultmedicine.medical_specialtyPoor prognosisTerm BirthEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEndometriumAtrophic endometriumEndometriumEndocrinologyPregnancymedicineHumansEmbryo ImplantationFull TermGynecologyOocyte Donationurogenital systemObstetricsbusiness.industryGene Expression ProfilingInfant NewbornObstetrics and GynecologyEmbryo Transferfemale genital diseases and pregnancy complicationsEmbryo transferRadiation therapymedicine.anatomical_structureFemaleEndometrial receptivityLive birthbusinessGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Age and Uterine Receptiveness: Predicting the Outcome of Oocyte Donation Cycles

2005

The impact of advancing age on uterine receptiveness has always been a concern of the medical establishment. Oocyte donation (OD) is the perfect model for ascertaining the extent of this relationship, but the literature is somewhat unreliable, mainly due to the limited samples on which the studies are based and insufficient control of important variables such as embryo quality.The present work was developed in a private infertility clinic.We retrospectively evaluate the results of 3089 OD cycles that ended up in a d 3 embryo transfer. Severe male factor infertility was an exclusion criterion.The impact of patients' age on pregnancy, implantation, and miscarriage rates and obstetric outcome …

Adultmedicine.medical_specialtyPregnancy RateEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)AbortionBiochemistryMiscarriageEndocrinologyPregnancyInternal medicineHumansMedicineEmbryo ImplantationRetrospective StudiesGynecologyPregnancyOocyte Donationbusiness.industryBiochemistry (medical)Retrospective cohort studyMiddle Agedmedicine.diseaseEmbryo transferAbortion SpontaneousPregnancy rateEndocrinologyMultivariate AnalysisFemalebusinessEmbryo qualityMaternal AgeThe Journal of Clinical Endocrinology &amp; Metabolism
researchProduct

Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors

2013

Objective To analyze the reproductive outcome of recipients of donated ova according to their body mass index (BMI). Design Twelve-year retrospective cohort analysis. Setting Fertility clinics. Patient(s) 9,587 first cycles of ovum donation with ova from normoweight donors. Intervention(s) Recipients divided according to their BMI to analyze IVF laboratory and outcome parameters: lean with BMI 2 (n = 1,458; 15.2%); normoweight with BMI 20–24.9 kg/m 2 (n = 5,706; 59.5%), overweight with BMI 25–29.9 kg/m 2 (n = 1,770; 18.5%), and obese with BMI ≥30 kg/m 2 (n = 653; 6.8%). Main Outcome Measure(s) Implantation, biochemical and clinical pregnancy, miscarriage, and live-birth rates. Result(s) In …

Adultmedicine.medical_specialtyPregnancy RateFertilization in VitroOverweightBody Mass IndexMiscarriagePregnancyRisk FactorsOdds RatioHumansMedicineEmbryo ImplantationObesityTwin PregnancyRetrospective StudiesGynecologyAnalysis of VariancePregnancyChi-Square DistributionOocyte Donationbusiness.industryObstetricsBody WeightUterusnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseaseObesityTissue DonorsAbortion SpontaneousPregnancy rateLogistic ModelsTreatment OutcomeReproductive MedicineSpainPregnancy TwinFemalemedicine.symptomLive birthbusinessInfertility FemaleLive BirthBody mass indexFertility and Sterility
researchProduct

Analysis of serum and endometrial progesterone in determining endometrial receptivity.

2021

Abstract STUDY QUESTION Is there a relationship between serum and endometrial progesterone (P4) levels, including P4 and metabolites (oestrone, oestradiol and 17α-hydroxyprogesterone), and endometrial receptivity? SUMMARY ANSWER Serum P4 levels were not correlated with endometrial P4, nor associated with endometrial receptivity as determined by the ERA® test; however, endometrial P4 and 17α-hydroxyprogesterone levels were positively correlated and related to endometrial receptivity by ERA. WHAT IS KNOWN ALREADY Acquisition of endometrial receptivity is governed by P4, which induces secretory transformation. A close relationship between serum P4 and pregnancy outcome is reported for hormone …

Adultmedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentPopulationUterusLuteal phaseEndometriumEndometriumPregnancyMedicine17a-hydroxyprogesterone ERA test P4 endometrial receptivity progesterone steroid hormones metabolitesHumansEmbryo ImplantationProspective StudieseducationProspective cohort studyProgesteroneGynecologyeducation.field_of_studyPregnancymedicine.diagnostic_testbusiness.industryRehabilitationObstetrics and GynecologyHormone replacement therapy (menopause)medicine.diseaseEmbryo Transfermedicine.anatomical_structureReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsEndometrial biopsyHuman reproduction (Oxford, England)
researchProduct